Skip to main content

1-2 of 2 results for subject:Macugen

Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

That guidance will be very welcome in explaining the position to authorities that do not understand the existing law. May we have a debate on the decision of the National Institute for Health and Clinical Excellence to restrict access to lucentis and macugen for wet age-related macular degeneration? I recognise...

Member
David Heath (Liberal Democrat)
Type
Business questions
Date
14 June 2007
Reference
461 c869-70
House
House of Commons

In respect of the first point, the hon. Gentleman comes to this issue with a great deal of professional expertise. All of us understand that age-related macular degeneration is a distressing condition for patients and their carers. We are committed to supporting the national health service to deliver improved eye-care...

Member
Jack Straw (Labour)
Type
Proceeding contributions
Date
14 June 2007
Reference
461 c869-70
House
House of Commons